Literature DB >> 24075869

Disruption of helix-capping residues 671 and 674 reveals a role in HIV-1 entry for a specialized hinge segment of the membrane proximal external region of gp41.

Zhen-Yu J Sun1, Yuxing Cheng2, Mikyung Kim3, Likai Song4, Jaewon Choi2, Ulrich J Kudahl5, Vladimir Brusic6, Barnali Chowdhury4, Lu Yu4, Michael S Seaman7, Gaëtan Bellot8, William M Shih8, Gerhard Wagner1, Ellis L Reinherz9.   

Abstract

HIV-1 (human immunodeficiency virus type 1) uses its trimeric gp160 envelope (Env) protein consisting of non-covalently associated gp120 and gp41 subunits to mediate entry into human T lymphocytes. A facile virus fusion mechanism compensates for the sparse Env copy number observed on viral particles and includes a 22-amino-acid, lentivirus-specific adaptation at the gp41 base (amino acid residues 662-683), termed the membrane proximal external region (MPER). We show by NMR and EPR that the MPER consists of a structurally conserved pair of viral lipid-immersed helices separated by a hinge with tandem joints that can be locked by capping residues between helices. This design fosters efficient HIV-1 fusion via interconverting structures while, at the same time, affording immune escape. Disruption of both joints by double alanine mutations at Env positions 671 and 674 (AA) results in attenuation of Env-mediated cell-cell fusion and hemifusion, as well as viral infectivity mediated by both CD4-dependent and CD4-independent viruses. The potential mechanism of disruption was revealed by structural analysis of MPER conformational changes induced by AA mutation. A deeper acyl chain-buried MPER middle section and the elimination of cross-hinge rigid-body motion almost certainly impede requisite structural rearrangements during the fusion process, explaining the absence of MPER AA variants among all known naturally occurring HIV-1 viral sequences. Furthermore, those broadly neutralization antibodies directed against the HIV-1 MPER exploit the tandem joint architecture involving helix capping, thereby disrupting hinge function.
© 2013.

Entities:  

Keywords:  NMR solution structure; broadly neutralizing antibody; helix capping; helix–hinge–helix motif; viral membrane fusion

Mesh:

Substances:

Year:  2013        PMID: 24075869      PMCID: PMC3934758          DOI: 10.1016/j.jmb.2013.09.030

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  40 in total

1.  The Xplor-NIH NMR molecular structure determination package.

Authors:  Charles D Schwieters; John J Kuszewski; Nico Tjandra; G Marius Clore
Journal:  J Magn Reson       Date:  2003-01       Impact factor: 2.229

2.  N- and C-capping preferences for all 20 amino acids in alpha-helical peptides.

Authors:  A J Doig; R L Baldwin
Journal:  Protein Sci       Date:  1995-07       Impact factor: 6.725

3.  Atomic structure of a thermostable subdomain of HIV-1 gp41.

Authors:  K Tan; J Liu; J Wang; S Shen; M Lu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

4.  Atomic structure of the ectodomain from HIV-1 gp41.

Authors:  W Weissenhorn; A Dessen; S C Harrison; J J Skehel; D C Wiley
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

5.  Measurement of one-bond 15N-13C' dipolar couplings in medium sized proteins.

Authors:  J J Chou; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  2000-10       Impact factor: 2.835

6.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

7.  Amino acid preferences for specific locations at the ends of alpha helices.

Authors:  J S Richardson; D C Richardson
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

8.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

9.  The N-terminal capping propensities of the D-helix modulate the allosteric activation of the Escherichia coli cAMP receptor protein.

Authors:  Shaoning Yu; Rodrigo A Maillard; Alexey V Gribenko; J Ching Lee
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

10.  Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.

Authors:  Gilad Ofek; Min Tang; Anna Sambor; Hermann Katinger; John R Mascola; Richard Wyatt; Peter D Kwong
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more
  16 in total

1.  In Vivo Analysis of Infectivity, Fusogenicity, and Incorporation of a Mutagenic Viral Glycoprotein Library Reveals Determinants for Virus Incorporation.

Authors:  Daniel J Salamango; Khalid K Alam; Donald H Burke; Marc C Johnson
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

2.  The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region.

Authors:  Beatriz Apellániz; Edurne Rujas; Soraya Serrano; Koldo Morante; Kouhei Tsumoto; Jose M M Caaveiro; M Ángeles Jiménez; José L Nieva
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

3.  Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion.

Authors:  Vani G S Narasimhulu; Anna K Bellamy-McIntyre; Annamarie E Laumaea; Chan-Sien Lay; David N Harrison; Hannah A D King; Heidi E Drummer; Pantelis Poumbourios
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

4.  Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state.

Authors:  Yi Wang; Pavanjeet Kaur; Zhen-Yu J Sun; Mostafa A Elbahnasawy; Zahra Hayati; Zhi-Song Qiao; Nhat N Bui; Camila Chile; Mahmoud L Nasr; Gerhard Wagner; Jia-Huai Wang; Likai Song; Ellis L Reinherz; Mikyung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-17       Impact factor: 11.205

5.  Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization.

Authors:  Beatriz Apellániz; Edurne Rujas; Pablo Carravilla; José Requejo-Isidro; Nerea Huarte; Carmen Domene; José L Nieva
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

6.  Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.

Authors:  Vincent J Venditto; Lindsay Wieczorek; Sebastian Molnar; Fernando Teque; Gary Landucci; Douglas S Watson; Donald Forthal; Victoria R Polonis; Jay A Levy; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

7.  Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer.

Authors:  Jeong Hyun Lee; Gabriel Ozorowski; Andrew B Ward
Journal:  Science       Date:  2016-03-04       Impact factor: 47.728

8.  Characterizing the Murine Leukemia Virus Envelope Glycoprotein Membrane-Spanning Domain for Its Roles in Interface Alignment and Fusogenicity.

Authors:  Daniel J Salamango; Marc C Johnson
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

Review 9.  Peptide-based Fusion Inhibitors for Preventing the Six-helix Bundle Formation of Class I Fusion Proteins: HIV and Beyond.

Authors:  Ajit Monteiro; Karl O A Yu; Mark D Hicar
Journal:  Curr HIV Res       Date:  2021       Impact factor: 1.341

10.  Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity.

Authors:  Luke R Donius; Yuxing Cheng; Jaewon Choi; Zhen-Yu J Sun; Melissa Hanson; Michael Zhang; Todd M Gierahn; Susanna Marquez; Mohammed Uduman; Steven H Kleinstein; Darrell Irvine; J Christopher Love; Ellis L Reinherz; Mikyung Kim
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.